Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
LB Pharmaceuticals Inc is a late-stage biopharmaceutical company developing novel therapies for the treatment of a wide range of neuropsychiatric disorders including schizophrenia, bipolar depression, adjunctive treatment of depressive disorder and...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of LB Pharmaceuticals (NASDAQ:LBRX) through any online brokerage.
Other companies in LB Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
LB Pharmaceuticals has a consensus price target of $51.88.
The stock price for LB Pharmaceuticals (NASDAQ: LBRX) is $36.99 last updated October 2, 2026 at 4:00 PM EDT.
There are no upcoming dividends for LB Pharmaceuticals.
LB Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for LB Pharmaceuticals.
LB Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.